MedPath
HSA Approval

HIZIN LIQUID 10 mg/5 ml

SIN03569P

HIZIN LIQUID 10 mg/5 ml

HIZIN LIQUID 10 mg/5 ml

July 4, 1989

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

ORAL

Medical Information

N05BB01

hydroxyzine

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

OLIC (THAILAND) LTD

Active Ingredients

HYDROXYZINE HCl

10 mg/5 ml

Hydroxyzine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HIZIN LIQUID 10 mg/5 ml - HSA Approval | MedPath